Virtu Financial’s Dova Pharmaceuticals, Inc. Common Stock DOVA Stock Holding History

Virtu Financial’s Portfolio DOVA Stock Details DOVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-18,729	Closed	-$523K	–	2052
2019 Q3	$523K	Buy	18,729 +5,944	+46%	+$96.3K	0.04%	496
2019 Q2	$180K	Buy	+12,785	New	+$122K	0.01%	1043
2018 Q1	–	Sell	-11,783	Closed	-$339K	–	2959
2017 Q4	$339K	Buy	+11,783	New	+$323K	0.02%	1157

Virtu Financial's DOVA Position: Q4 2019 in Review

Virtu Financial sold out of Dova Pharmaceuticals, Inc. Common Stock (DOVA) in Q4 2019, closing a stake of 18,729 shares — an estimated $523K sold.

Virtu Financial first reported a position in DOVA in Q4 2017 and held it in 3 quarters. The position peaked at $523K in Q3 2019. 0 funds tracked by Wall St. Rank hold DOVA as of Q4 2019.

Virtu Financial reported no remaining Dova Pharmaceuticals, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
Virtu Financial sold 18,729 Dova Pharmaceuticals, Inc. Common Stock shares in Q4 2019, an estimated $523K.
Virtu Financial first reported a position in Dova Pharmaceuticals, Inc. Common Stock in Q4 2017 and held it in 3 quarters.
Virtu Financial's Dova Pharmaceuticals, Inc. Common Stock position peaked at $523K in Q3 2019.
0 funds tracked by Wall St. Rank held Dova Pharmaceuticals, Inc. Common Stock as of Q4 2019.

Based on Virtu Financial's 13F filing for Q4 2019, filed 4 Feb 2020.